Sam's Club Pharmacy vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Walmart-owned warehouse club pharmacy with 500+ locations; bulk purchasing enables discounted $4/$10 generics competing with Costco Pharmacy as part of Walmart's health services strategy.
About
Sam's Club Pharmacy is the pharmacy division operating within Sam's Club warehouse membership clubs, providing prescription filling, immunizations, health screenings, and specialty pharmacy services to Sam's Club members at competitive pricing leveraging Walmart's pharmaceutical purchasing scale. Part of Walmart Inc. (NYSE: WMT), Sam's Club Pharmacy operates more than 500 pharmacy locations inside Sam's Club warehouse clubs across the United States, offering members discounted prescription pricing as part of the Sam's Club membership value proposition.\n\nSam's Club Pharmacy's competitive advantage lies in Walmart's massive pharmaceutical purchasing power — the combined Walmart/Sam's Club pharmacy network is one of the largest in the US, enabling negotiated drug pricing that can undercut traditional retail pharmacies. Members access prescriptions at Sam's Club prices with convenient access during their warehouse shopping trips. The pharmacy offers $4/$10 generic prescription pricing for common medications, mail-order options, and immunization services.\n\nIn 2025, Sam's Club Pharmacy operates within Walmart's broader health strategy — Walmart Health (primary care clinics) and Walmart+ pharmacy benefits are being integrated to create a comprehensive health services ecosystem for Walmart and Sam's Club customers. The retail pharmacy market faces structural challenges from pharmacy benefit manager (PBM) reimbursement pressure that has forced independent and chain pharmacy closures. Sam's Club Pharmacy competes with Costco Pharmacy (similar warehouse model), CVS, Walgreens, and mail-order PBM pharmacies. The 2025 strategy focuses on expanding specialty pharmacy capabilities, integrating prescription benefits with Walmart+ membership, and growing immunization and preventive health services.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.